CMS Blood Platelet Transfusion Coverage Policy Update: What Billing Teams Need to Know (NCD 44)

CMS has issued a modification to National Coverage Determination (NCD) 44, which governs Medicare coverage for blood platelet transfusions. This update, effective March 12, 2026, touches billing across inpatient hospital services, outpatient hospital services incident to a physician's service, and physicians' services. If your facility performs platelet transfusions for Medicare beneficiaries, here's what you need to understand before claims hit your queue.

Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Blood Platelet Transfusions
Policy Code NCD 44
Change Type Modified
Effective Date 2026-03-12
Impact Level Medium
Specialties Affected Hematology, Oncology, Transfusion Medicine, Hospital Medicine, General Surgery
Key Action Audit your medical necessity documentation for platelet transfusion claims to confirm the record supports "reasonable and necessary" language aligned with this updated NCD.

What CMS NCD 44 Covers for Blood Platelet Transfusions

The Centers for Medicare & Medicaid Services has determined that blood platelet transfusions—sometimes referred to as blood platelet transplants in legacy CMS language—are both safe and effective for correcting thrombocytopenia and other blood defects. Under this NCD, Medicare will cover platelet transfusions when treatment is reasonable and necessary for the individual patient.

That phrase—"reasonable and necessary"—is doing a lot of work here. It's the central medical necessity standard CMS applies, and it means coverage is evaluated on a case-by-case basis rather than through a blanket approval for any thrombocytopenic patient. Your documentation needs to support clinical justification specific to the individual, not just the diagnosis.

The policy applies across three benefit categories:

This multi-setting coverage means NCD 44 is relevant whether your billing team handles hospital facility claims, outpatient services, or professional fee billing—and each setting carries its own documentation and coding requirements.


Medical Necessity Criteria Under CMS NCD 44

CMS does not enumerate a rigid list of qualifying diagnoses in this NCD beyond thrombocytopenia and "other blood defects." That broad framing gives providers some flexibility but also places the documentation burden squarely on the treating physician.

For claims to survive audit or prepayment review, the medical record should clearly establish:

#Covered Indication
1A documented diagnosis of thrombocytopenia or another qualifying blood defect
2Clinical rationale explaining why the transfusion is reasonable and necessary for this specific patient
3Platelet count values and clinical indicators that informed the transfusion decision
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Thrombocytopenia itself is not automatically sufficient to trigger coverage. A platelet count below a certain threshold may be clinically relevant, but the record needs to tell the full story—why this patient, why this intervention, why now. Reviewers will look for treating physician documentation that ties those pieces together explicitly.


Which Benefit Categories Apply—and Why It Matters for Billing

The distinction between benefit categories matters because it affects how claims are submitted, what modifiers may be required, and where liability falls if coverage is denied.

For inpatient hospital services, the platelet transfusion is generally bundled into the DRG payment and won't appear as a separately billable line item under the facility claim. The medical necessity documentation still matters because it supports the underlying DRG and protects against denial on audit.

For outpatient hospital services incident to a physician's service, the transfusion may be billed separately under the facility claim—making accurate HCPCS coding and documented physician involvement essential. "Incident to" requirements mean a physician must be present or immediately available, and that relationship should be reflected in the documentation.

For physicians' services, the professional component of the transfusion—including interpretation, supervision, and management—may be separately billable, depending on the clinical setting and provider role.


Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
Re-review every 24 monthsRe-review every 12 months with updated clinical documentation

Affected Codes

NCD 44 as modified does not specify particular CPT or HCPCS codes within the policy document itself. The policy does not list covered or non-covered codes, and no ICD-10-CM diagnosis codes are enumerated in the NCD text.

No specific CPT, HCPCS, or ICD-10 codes are listed in this policy.

This means your coding team will need to apply standard coding conventions for platelet transfusion services based on the clinical documentation and payer-specific billing guidance, without relying on a defined code list within the NCD itself. Work with your coding staff or a certified coder to confirm the appropriate codes for each setting of service, since the absence of enumerated codes here does not eliminate the need for precise coding on the claim.


Prior Authorization Requirements Under NCD 44

NCD 44 does not include prior authorization requirements as stated in the current policy modification. Coverage is determined by whether the service meets the "reasonable and necessary" standard at the time of claim review, not through a prospective prior approval process at the NCD level.

That said, individual Medicare Advantage plans—which operate under approved CMS frameworks but can impose additional coverage requirements—may have their own prior authorization rules for platelet transfusions. If your patients are enrolled in Medicare Advantage rather than traditional fee-for-service Medicare, verify the plan's requirements separately before assuming NCD 44 is the end of the story.


This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

What Your Billing Team Should Do

#Action Item
1

Audit open and recent claims before March 12, 2026. Pull any platelet transfusion claims currently in your revenue cycle and confirm the medical necessity documentation meets the "reasonable and necessary" standard under this modified NCD. Identify and correct gaps before the effective date.

2

Update your CDI (clinical documentation improvement) prompts for platelet transfusions. Work with your CDI team and treating physicians to ensure that every platelet transfusion order includes explicit documentation of the clinical rationale—platelet counts, diagnosis, and why the intervention was deemed necessary for this individual patient.

3

Differentiate your billing workflows by setting. Since NCD 44 spans inpatient, outpatient, and physician services, confirm that each service line has a distinct documentation and coding protocol. Bundling rules, incident-to requirements, and physician involvement standards differ by setting—treat them accordingly.

+ 2 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee